Changes in acetylator phenotype over the lifespan in the Wistar rat

Mechanisms of Ageing and Development

Volumn 127, Issue 1, 2006, Pages 73-78

  Lares Asseff, Ismael ^a   Camacho, Guadalupe A ^b   Guillé, Adrián J ^b   Toledo, Alejandra R ^b   Trujillo, Francisca ^b   Reyes, Rosa E ^b   Juárez, Hugo M ^b,c   Pérez, Gabriela ^b  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Acetylator phenotype; Age; Metabolism; Rat

Indexed keywords

SULFADIAZINE;

ACETYLATION; ACETYLATOR PHENOTYPE; AGE DISTRIBUTION; ANIMAL EXPERIMENT; ARTICLE; CLASSIFICATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG METABOLISM; GENE EXPRESSION; GROWTH, DEVELOPMENT AND AGING; LIFESPAN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; URINALYSIS; VALIDATION PROCESS;

ACETYLATION; AGING; ANIMALS; LONGITUDINAL STUDIES; MALE; PHENOTYPE; RATS; RATS, WISTAR; SULFADIAZINE; TIME FACTORS;

ANIMALIA; RATTUS NORVEGICUS;

EID: 28244486119     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2005.09.009     Document Type: Article

References (29)

1. A.P. Alvares, S. Kapelner, and A. Kappas Drug metabolism in normal children, lead poisoned children and normal adults Clin. Pharmacol. Ther. 17 1975 179 183
2. M.A. Correia Biotransformación de Fármacos B.G. Katzung Farmacología Básica y Clínica 1996 El Manual Moderno México 61 74
3. P. du Souich, J.A. McLean, K. Stoeckel, D. Ohlendorf, and M. Gibaldi Screening methods using sulfamethazine for determining acetylator phenotype Clin. Pharmacol. Ther. 26 1979 757 765
4. L.P. Eidus, M. Varughese, M.A. Hodgkin, M.E. Hsu, and K.B. McRae Simplification of isoniazid phenotyping procedure to promote its application in the chemotherapy of tuberculosis Bull. Wild Health Org. 49 1973 507 516
5. L. Eidus, A.M.T. Harnanansingh, and A.G. Jessamine Urine test for phenotyping isoniazid inactivators Am. Rev. Resp. Dis. 104 1971 587 591
6. D.A.P. Evans, K.A. Manley, and V.A. Mckusick Genetic control of isoniazid metabolism in man Br. Med. J. 2 1960 485 491
7. D.A.P. Evans, and T.A. White Human acetylation polymorphism J. Lab. Clin. Med. 63 1964 394 403
8. D.A.P. Evans An improved and simplified method of detecting the acetylator phenotype J. Med. Genet. 6 1969 405 407
9. C. Friis, H.N. Gyrd, P. Nielsen, C.E. Olsen, and F. Rasmussen Pharmacokinetics and metabolism of suphadiazine in neonatal and young pigs Acta Pharmacol. Toxicol. 54 1984 321 326
10. R. Gelber, J.H. Peters, G.R. Gordon, A.J. Glazko, and L. Levy The polymorphic acetylation of dapsone in man Clin. Parmacol. Ther. 12 1971 225 238
11. D.W. Hein Acetylator genotype and arylamine induced carcinogenesis Biochim. Biophys. Acta 948 1988 37 66
12. A. Hutchings, and A. Routledge A simple method for determining acetylator phenotype using isoniazid Br. J. Clin. Pharmacol. 22 1986 343 345
13. T. Inaba, and T.D. Arias On phenotyping with isoniazid: The use of urinary acetylation ratio and the uniqueness of antimodes. Study of two Amerindian populations Clin. Pharmacol. Ther. 42 1987 493 497
14. L. Iselius, and D.A.P. Evans Formal genetics of isoniazid metabolism in man Clin. Pharmacokinet. 8 1983 541 544
15. M. Meisel, T. Schneider, W. Siegmund, S. Nikschick, K.J. Klebingat, and A. Scherber Development of human polymorphic N-acetyltransferase Biol. Res. Pregn. Perinatol. 7 1986 74 76
16. P. Meisel, D. Arndt, E. Scheuch, K.J. Klebingat, and W. Siegmund Prediction of metabolic activity from genotype: the gene-dose effect on N-acetyltransferase Ther. Drug Monit. 23 2001 9 14
17. U.A. Meyer Genetic polymorphism of drug metabolism Fundam. Clin. Pharmacol. 4 6 1990 595 615
18. U.A. Meyer Polymorphism of human acetyltransferases Environ. Health Perspect. 102 1994 213 216
19. M. Paire, J. Lavarenne, and M.F. Rodet Inactivation of isoniazid in children Therapie 39 1984 625 631
20. K.A. Pariente, E. Rey, D. Gendrel, K.F. Vauzelle, O. Crémier, and P. d'Athis Isoniazid acetylation metabolic ratio during maturation in children Clin. Pharmacol. Ther. 62 1997 377 383
21. G. Pons, E. Rey, O. Carrier, M.O. Richard, C. Moran, and J. Badoual Maturation of AFMU excretion in infants Fundam. Clin. Pharmacol. 3 1989 589 595
22. Stanton, A.G., 1992. Primer of biostatistics program. McGraw-Hill Inc., Version 3.02.
23. H. Schröder, and D.A.P. Evans The polymorphic acetylation of sulphapyridine in man J. Med. Gent. 9 1972 168 171
24. Szórady, I., 1980. Pharmacogenetics. Aspects in neonatal drug response. Abstracts XVI International Congress of Pediatrics, pp. 347.
25. K.P. Vatsis, W.W. Weber, and D.A. Bell Nomenclature for N-acetyltansferases Pharmacogenetics 5 1995 1 17
26. 4-acetylsulphamethoxazole Clin. Pharmacokinet. 3 1978 319 329
27. T.B. Vree, Y.A. Hekster, A.M. Baars, J.E. Damsma, and E. van der Kleijn Determination of trimethoprim and sulfamethoxazole (co-trimoxazole) in body fluids of man by means of high-performance liquid chromatography J. Chromatogr. 146 1978 103 112
28. W.W. Weber, and D.W. Hein N-acetylation pharmacogenetics Pharmacol. Rev. 37 1985 25 79
29. W.W. Weber Acetylation Birth Defects Orig. Artic. Ser. 26 1990 43 65